Fund Holdings — Krensavage Asset Management, LLC

Total Portfolio Value:
$178.5K
Total Bought:
$8.2K
Total Sold:
$54.8K
Net Transaction:
-$46.6K
Securities
▲▼
SharesValue
Q2 2024
▲▼
Q3 2024
▲▼
Change
▲▼
Q2 2024
▲▼
Q3 2024
▲▼
Weight (%)
▲▼
Change
▲▼
United Therapeutics Corporation(UTHR)118,208100,332-17,876$37.7K$36.0K20.15%-$1.7K
Exelixis, Inc.(EXEL)1,677,3931,281,612-395,781$37.7K$33.3K18.64%-$4.4K
Cardinal Health, Inc.(CAH)217,656210,263-7,393$21.4K$23.2K13.02%+$1.8K
Biogen Inc.(BIIB)123,785113,502-10,283$28.7K$22.0K12.33%-$6.7K
Enanta Pharmaceuticals, Inc.(ENTA)1,251,3381,498,074+246,736$16.2K$15.5K8.70%-$710
Jazz Pharmaceuticals plc(JAZZ)109,076110,257+1,181$11.6K$12.3K6.88%+$642
BioNTech SE(BNTX)132,29393,583-38,710$10.6K$11.1K6.23%+$484
Sanofi(SNY)153,832150,205-3,627$7.5K$8.7K4.85%+$1.2K
Alkermes plc(ALKS)257,554251,495-6,059$6.2K$7.0K3.94%+$832
Indivior Plc0701,873+701,873$0$6.8K3.83%+$6.8K
Vanda Pharmaceuticals Inc.(VNDA)662,166414,684-247,482$3.7K$1.9K1.09%-$1.8K
Regeneron Pharmaceuticals, Inc.(REGN)7,853353-7,500$8.3K$3710.21%-$7.9K
Mural Oncology Plc75,05775,868+811$236$2370.13%+$1
Taro Pharmaceutical Indus650,0890-650,089$28.0K$0—-$28.0K
Page 1 of 1